コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 RV also induced lung mRNA and protein expression of pro-
2 RV dysfunction (hazard ratio [HR]: 2.57; 95% confidence
3 RV dysfunction increased stepwise in relation to RV cham
4 RV failure showed lower oxidative phosphorylation (moder
5 RV failure was characterized by an increase in 4HNE addu
6 RV function improved as measured by central venous press
7 RV indices provided additional risk stratification beyon
8 RV infection increased the numbers of bronchial mucosal
9 RV infection of 6-day-old immature mice causes mucous me
10 RV infection was also associated with more severe diseas
11 RV recovery was defined as improvements in central venou
12 RV RNA was found in 88.9% of monocytes from infected HG
13 RV-A and RV-C, therefore, induce qualitatively different
14 RV-C induced higher expression of CCL24 (eotaxin-2) than
16 OR, not available; AFE, approximately 100%), RV (OR, 7.1 [95% CI, 3.7-13.6]; AFE, 86%) and CoV (OR, 2
17 n peripheral blood mononuclear cells from 11 RV-infected hypogammaglobulinemia patients, 7 RV-infecte
18 y 6 of life plus sham on day 13 of life, (2) RV-A1B on day 6 plus sham on day 13, (3) sham on day 6 p
21 V-infected hypogammaglobulinemia patients, 7 RV-infected control subjects, and 14 noninfected control
25 h clinical deterioration at follow-up, acute RV dysfunction, with or without deep vein thrombosis, is
29 elevations; the predictive value of adverse RV remodeling was similar irrespective of whether analys
30 se of this study was to test whether adverse RV remodeling (dysfunction/dilation) predicts COVID-19 p
31 ath was greatest among patients with adverse RV remodeling and positive biomarkers and was lesser amo
34 O) was demonstrated to be protective against RV dilatation in patients with repaired tetralogy of Fal
36 CDHR3 EC1 contacts C15a, and presumably all RV-Cs, in a unique cohesive footprint near the threefold
39 massive or massive pulmonary embolism and an RV/LV diameter ratio >=0.9 on chest computed tomography.
40 whereas mice infected with sham on day 6 and RV-A2 on day 13 of life demonstrated increased IFN-gamma
41 T-cell memory responses induced by RV-A and RV-C in children with and without asthma.Methods: Periph
42 without asthma were lower for both RV-A and RV-C while retaining the pattern of gene expression and
46 Four compounds showed broad-spectrum EV and RV activity and inhibited contemporary strains of emergi
49 Our results demonstrated that the LV and RV of human donor hearts have distinct responses to cold
50 Samples of left and right ventricle (LV and RV) free wall collected from 32 Wistar rats were subject
51 cant relationship between measures of PR and RV volumes in patients after TOF repair with concomitant
52 ng of LV forward flow, filling pressure, and RV function allowed categorization of patients hospitali
54 lations were observed between PRF or PRV and RV ejection fraction (r = -0.04; p = 0.87 and r = -0.03;
56 nged terminal activation duration (TAD), and RV enlargement by echocardiogram, and together with JUP
63 fter adjusting for age, gender, and baseline RV/LV ratio, pulmonary artery systolic pressure, and mod
64 t, mice infected with RV-A1B on day 6 before RV-A2 infection on day 13 showed increased expression of
65 ified a novel, biological difference between RV and LV fibroblasts that might underlie distinctions i
67 ith those without asthma were lower for both RV-A and RV-C while retaining the pattern of gene expres
68 4 distinct endotypes-mainly characterized by RV species, microbiome, and type 2 cytokine (T2) respons
69 d compare T-cell memory responses induced by RV-A and RV-C in children with and without asthma.Method
75 ctivation of the IL-17A pathway.Conclusions: RV-C induced memory cells with a lower IFN-gamma-type re
77 o D-RVd or RVd induction (4 cycles), ASCT, D-RVd or RVd consolidation (2 cycles), and lenalidomide or
78 he end of post-ASCT consolidation, favored D-RVd vs RVd (42.4% vs 32.0%; odds ratio, 1.57; 95% confid
79 dian CD34+ cell yield was 8.2 x 106/kg for D-RVd and 9.4 x 106/kg for RVd, although plerixafor use wa
80 responses deepened; sCR rates improved for D-RVd vs RVd (62.6% vs 45.4%; P = .0177), as did minimal r
81 The addition of daratumumab (D) to RVd (D-RVd) in transplant-eligible NDMM patients was evaluated.
83 Patients (N = 207) were randomized 1:1 to D-RVd or RVd induction (4 cycles), ASCT, D-RVd or RVd cons
88 V) lead length was associated with decreased RV sensing (beta = -0.012 mV, P = .05) and reduced RV ca
94 avage of multiple intestinal caspases during RV infection is mediated by the IFN-STAT1 signaling path
95 erent intestinal interferon receptors during RV infection eliminates several innate and inflammatory
101 The simian RRV strain, but not murine EW RV, uniquely triggers the cleavage of both extrinsic and
102 Kinetic studies indicated that sustained EW RV replication and IFN induction in the small intestine
104 nfection baseline and following experimental RV infection in 17 Global Initiative for Chronic Obstruc
105 d phospho-pyruvate dehydrogenase expression, RV fibrosis, and hypertrophy and improved RV function.
108 inflammation and mucous metaplasia following RV infection by suppressing epithelial cell innate cytok
114 Palmitoylation of STING was not required for RV-A16 replication, nor was the C-terminal tail of STING
116 r RV-C are lower than responses specific for RV-A, suggesting poor immunity to this species.Objective
117 noviruses (RVs), although those specific for RV-C are lower than responses specific for RV-A, suggest
118 8.2 x 106/kg for D-RVd and 9.4 x 106/kg for RVd, although plerixafor use was more common with D-RVd.
120 these findings demonstrate that the healthy RV is not merely a passive conduit, but actively partici
122 nfection with a STAT1-sensitive heterologous RV strain induced IFN-stimulated transcripts, inflammato
123 (from 60.6 +/- 14.2 to 33.8 +/- 10.7 mm Hg), RV/left ventricular ratio (from 1.19 +/- 0.33 to 0.87 +/
125 cytokines were also suppressed by homologous RV, as was intestinal damage in response to endotoxin.
126 In contrast to infection with homologous RV, infection with a STAT1-sensitive heterologous RV str
128 ecovered the simian RV RRV strain, the human RV CDC-9 strain, a reassortant between murine RV D6/2 an
135 s markedly upregulated miR-21 and miR-221 in RV fibroblasts but not in LV fibroblasts nor cardiomyocy
136 e model adjusted R(2) for absolute change in RV/LV ratio, pulmonary artery systolic pressure, modifie
140 nt ventricular tachycardia, >10% increase in RV endocardial surface area of bipolar voltage consisten
141 re associated with a significant increase in RV volume (bipolar: Spearman rho, 0.6965, P=0.006; unipo
143 e previously identified two forms of NSP2 in RV-infected cells, a cytoplasmically dispersed form (dNS
145 role of mitochondrial metabolism of RVfib in RV fibrosis in human and experimental pulmonary arterial
147 of clinical and imaging variables, including RV function, both TRF (adjusted hazard ratio [AHR] per 1
148 redictors of inducible VT included increased RV LGE (odds ratio [OR], 1.15; P=0.001 per cm(3)), incre
149 IL-1RA, anti-IL-1beta, or NLRP3 KO increased RV-induced type 2 cytokine immune responses, ILC2 number
151 e in mean z scores for LV, left atrium (LA), RV, interventricular septum, and LV posterior wall diame
153 n, the human CDC-9 strain, and a murine-like RV strain, which is suitable for both in vitro and in vi
155 dict the observed risk in patients with lone RV but underestimated the risk in those with LV involvem
156 0.16 versus 1.36+/-0.15, P<0.0001) and lower RV inflow/outflow ratio (P<0.001), as compared to men.
160 iar biventricular adaptation, with higher LV/RV (1.41+/-0.16 versus 1.36+/-0.15, P<0.0001) and lower
162 muVs and 31 +/- 7 ms; both p < 0.05) and LVs+RV pacing (to 108 +/- 37 muVs; p < 0.05; and 29 +/- 8 ms
164 combination with right ventricular (RV) (LVs+RV), BiV, and HB pacing was performed in 27 patients und
166 otent form of oxidative stress, in mediating RV hypertrophy and failure in congenital heart disease i
167 ed lower oxidative phosphorylation (moderate RV hypertrophy, 287.6+/-19.75 versus RV failure, 137.8+/
169 V CDC-9 strain, a reassortant between murine RV D6/2 and simian RV SA11 strains, and several reassort
170 ethods have supported the recovery of murine RV, impeding the study of RV replication and pathogenesi
172 , and inflammatory functions, during natural RV intestinal infection.IMPORTANCE Rotavirus is a highly
174 t healthy ageing requires maintaining normal RV intra-cavity blood flow as quantified using KE method
175 dian progression-free survival was observed (RVd 33.64 months [95% CI 19.55-not reached], RVd-elotuzu
179 has not been fully studied in the context of RV infection in vivo Here, we present both in vitro and
182 served regions located on capsid proteins of RV A viruses, mice were sequentially vaccinated with DNA
184 cross-reactivity against multiple strains of RV A viruses by ELISA, including strains A1A, A1B, A15,
185 recovery of murine RV, impeding the study of RV replication and pathogenesis in an in vivo suckling m
194 or RVd induction (4 cycles), ASCT, D-RVd or RVd consolidation (2 cycles), and lenalidomide or lenali
195 ts (N = 207) were randomized 1:1 to D-RVd or RVd induction (4 cycles), ASCT, D-RVd or RVd consolidati
197 right ventricular (RV) pacing, particularly RV apical pacing, can have deleterious effects on cardia
198 plus sham on day 13, (3) sham on day 6 plus RV-A2 on day 13, and (4) RV-A1B on day 6 plus RV-A2 on d
200 tation information), a scalable and powerful RV association test method that effectively incorporates
201 ressure, pulmonary artery systolic pressure, RV/left ventricular ratio, and RV fractional area change
204 RVd 33.64 months [95% CI 19.55-not reached], RVd-elotuzumab 31.47 months [18.56-53.98]; hazard ratio
205 tial for the rescue of other hard-to-recover RV strains such as low-replicating attenuated vaccine ca
206 sing (beta = -0.012 mV, P = .05) and reduced RV capture threshold (beta = -0.002 V, P < .01) immediat
209 we have uncovered repressors of retrovirus (RV) activity as modifiers of CHMP2BIntron5 toxicity.
211 lammation following experimental rhinovirus (RV)-16-induced COPD exacerbations and its relationship t
216 ightened antibody responses to rhinoviruses (RVs), although those specific for RV-C are lower than re
218 ans or animals.IMPORTANCE Group A rotavirus (RV) remains as the single most important cause of severe
220 e(Haemophilus)T2(low); endotype C, virus(RSV/RV)microbiome(Streptococcus)T2(low); and endotype D, vir
222 In its most severe form, there is severe RV hypoplasia and poorly developed OFT resulting in earl
223 eassortant between murine RV D6/2 and simian RV SA11 strains, and several reassortants and reporter R
224 system, we successfully recovered the simian RV RRV strain, the human RV CDC-9 strain, a reassortant
226 higher expression of CCL24 (eotaxin-2) than RV-A in the responses of children with and without asthm
227 ls with a lower IFN-gamma-type response than RV-A without T-helper cell type 2 (Th2) upregulation.
229 ition of the molecular interface between the RV-Cs and their receptors provides new avenues that can
230 of the left ventricle and historically, the RV has even been referred to as a 'passive conduit' of l
231 ion-related genes were down-regulated in the RV and while oxidative phosphorylation genes were activa
232 ichloroacetate, at therapeutic levels in the RV, reduced phospho-pyruvate dehydrogenase expression, R
239 translocation of NFkappaB (p65), whereas the RV showed increased cell death close to the endocardium
240 here were no treatment-related deaths in the RVd group and one death in the RVd-elotuzumab group for
241 the D-RVd group and 7 patients (6.8%) in the RVd group progressed; respective 24-month progression-fr
242 grade 3-5 infections (four [8%] of 52 in the RVd group, eight [17%] of 48 in the RVd-elotuzumab group
243 and motor neuropathy (one [2%] of 52 in the RVd group, four [8%] of 48 in the RVd-elotuzumab group).
244 , sensory neuropathy (four [8%] of 52 in the RVd group, six [13%] of 48 in the RVd-elotuzumab group),
245 deaths in the RVd group and one death in the RVd-elotuzumab group for which study treatment was liste
246 52 in the RVd group, six [13%] of 48 in the RVd-elotuzumab group), and motor neuropathy (one [2%] of
247 2 in the RVd group, eight [17%] of 48 in the RVd-elotuzumab group), sensory neuropathy (four [8%] of
249 dings directly link endosomal dysfunction to RV de-repression in an FTD-ALS model without TDP-43 path
252 .Measurements and Main Results: Responses to RV-A showed higher expression of IFNG and STAT1 compared
253 R-21 and miR-221 upregulation is specific to RV cellular response to mechanical and hormonal stimuli
262 eft ventricle (LV, n=4) and right ventricle (RV, n=4) after 0, 4, and 8 hours of cold storage in hist
263 ne or in combination with right ventricular (RV) (LVs+RV), BiV, and HB pacing was performed in 27 pat
268 onfers augmented risk for right ventricular (RV) dysfunction and dilation; the prognostic utility of
271 patients (10%), isolated right ventricular (RV) involvement was found in 58 (41%), biventricular in
275 d advanced liver disease, right ventricular (RV) systolic pressure <40 mm Hg, and normal RV function
276 uted tomographic-measured right ventricular (RV)-to-left ventricular diameter ratio in massive and su
277 oderate RV hypertrophy, 287.6+/-19.75 versus RV failure, 137.8+/-11.57 pmol/[secxmL]; P=0.0004), and
279 2 cytokine (T2) response: endotype A, virus(RV-C)microbiome(mixed)T2(low); endotype B, virus(RV-A)mi
280 )microbiome(mixed)T2(low); endotype B, virus(RV-A)microbiome(Haemophilus)T2(low); endotype C, virus(R
282 requently infected with respiratory viruses (RVs) in the upper respiratory tract (URT), but the conco
283 3-month ICS/LABA treatment, residual volume (RV)/total lung capacity (TLC)% predicted was reduced com
284 of post-ASCT consolidation, favored D-RVd vs RVd (42.4% vs 32.0%; odds ratio, 1.57; 95% confidence in
285 es deepened; sCR rates improved for D-RVd vs RVd (62.6% vs 45.4%; P = .0177), as did minimal residual
286 s for ruling-out and ruling-in inducible VT, RV LGE >10 cm(3) was 100% sensitive and >36 cm(3) was 10
287 hocardiographic abnormality at follow-up was RV function deterioration (12 patients), followed by LV
291 lation and (ii) vNSP2 S313D colocalizes with RV-induced LDs without NSP5, suggesting that vNSP2 phosp
292 r expression of IFNG and STAT1 compared with RV-C, and significant expression of CXCL9, 10, and 11 wa